Most people with hairy cell leukaemia have a normal life expectancy. Treatment is very successful and usually puts the disease into remission (no evidence of hairy cell leukaemia on your tests). Remissions often last many years but hairy cell leukaemia usually comes back ( relapses) and needs more treatment at some point.
What You Should Know
Understanding Hairy Cell Leukemia: Diagnosis, Treatment and Beyond
Hairy cell leukemia prognosis depends on the growth of cancer cells as well as the response of the patient to the treatment. Overall, the prognosis for hairy cell leukemia is quite positive as most patients get back to leading a normal or near normal life. Read through the following article and know more about hairy cell leukemia and its survival rate.
Hairy cell leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Hairy cell leukemia is a cancer of the blood and bone marrow. This rare type of leukemia gets worse slowly or does not get worse at all.
Hairy cell leukemia not having achieved remission C91. 40 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C91. 40 became effective on October 1, 2021.
ICD-10-CM Code for Personal history of leukemia Z85. 6.
C95. 9 - Leukemia, unspecified. ICD-10-CM.
Hyperlipidemia, UnspecifiedCode E78. 5 is the diagnosis code used for Hyperlipidemia, Unspecified, a disorder of lipoprotein metabolism other lipidemias. It is a condition with excess lipids in the blood.
Definition. A neoplasm arising from hematopoietic cells found in the bone marrow, peripheral blood, lymph nodes and spleen (organs of the hematopoietic system).
The early history of leukemia reaches back 200 years. In 1811, Peter Cullen defined a case of splenitis acutus with unexplainable milky blood. Alfred Velpeau defined the leukemia associated symptoms, and observed pus in the blood vessels (1825). Alfred Donné detected a maturation arrest of the white blood cells (1844).
Z80. 6 - Family history of leukemia. ICD-10-CM.
By convention, the history of chronic lymphocytic leukemia (CLL) begins in 1845, but it could be said to have started when the first white cells, “the globuli albicanates,” were noted by Joseph Lieutaud in 1749 (1).
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Leukemia of unspecified cell type A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.
CPT Codes*: 88184(x1), 88185(x22), 88189(x1). Additional 88185 CPTs may be added if initial screen is abnormal.
Hairy cell leukemia(HCL) is a rare subtype of chronic lymphocytic leukemia (CLL)that progresses slowly. HCL is caused when bone marrow makes too many B cells (lymphocytes), a type of white blood cell that fights infection.
Hairy cell leukaemia variant Despite its name, it is classed as a form of non-Hodgkin lymphoma. It is very rare. Like classical hairy cell leukaemia, the abnormal cells in HCL-V look hairy under a microscope.
Hairy cell leukemia variant is a rare disorder accounting for approximately 0.4% of chronic lymphoid malignancies and 10% of all HCL cases. The disease affects the elderly population without sexual predominance. The median age of the patients is 71 years.
Leukemia, unspecified not having achieved remissionC95. 90 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.The 2022 edition of ICD-10-CM C95. 90 became effective on October 1, 2021.This is the American ICD-10-CM version of C95.
Hairy cell leukemia, in remission 1 C91.41 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM C91.41 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of C91.41 - other international versions of ICD-10 C91.41 may differ.
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A rare type of leukemia in which abnormal b-lymphocytes (a type of white blood cell) are present in the bone marrow, spleen, and peripheral blood. When viewed under a microscope, these cells appear to be covered with tiny hair-like projections.
Neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of hairy or flagellated cells in the blood and bone marrow.
Hairy cell leukemia is an uncommon hematological malignancy characterized by an accumulation of abnormal B lymphocytes. It is usually classified as a sub-type of chronic lymphoid leukemia. Hairy cell leukemia makes up approximately 2% of all leukemias, with fewer than 2,000 new cases diagnosed annually in North America and Western Europe combined.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code C91.4. Click on any term below to browse the alphabetical index.